Factor VIII/IX inhibitor testing practices in the United Kingdom: Results of a UKHCDO and UKNEQAS national survey.
Paul BattyAnne RiddellSteve KitchenSofia Sardo InfirriIsobel WalkerTim WoodsIan JenningsDaniel P HartPublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2021)
Heterogeneity was seen at each stage of assay methodology. No assay-related factors were found to explain variation in inhibitor titres. Further standardization is required to improve inhibitor quantification to guide patient care.